All three indexes have opened relatively flat this morning as traders brace for the major events this month, the FOMC meeting and the informal Russia/OPEC meeting.
Among the stocks grabbing trader’s attention include iRobot Corporation (NASDAQ:IRBT), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Intel Corporation (NASDAQ:INTC), Transocean LTD (NYSE:RIG), and Seadrill Ltd (NYSE:SDRL). Let’s find out why each stock is on traders’ radars and see what the funds from our database think about them.
We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).
iRobot Corporation (NASDAQ:IRBT) shares are 2.3% in the green today after Needham raised its price target on the stock to $46 from $42. The Needham analyst, James Ricchiuti, is more optimistic about the company’s future after meeting with iRobot’s top executives. In particular, Ricchiuti thinks that there are many ways the Roomba manufacturer can deliver earnings surprises in its consumer segment. Needless to say, the analyst has a ‘Buy’ rating on the stock. Shares of iRobot Corporation (NASDAQ:IRBT) are near a 52-week high and have rallied by over 11% year-to-date. Willem Mesdag‘s Red Mountain Capital owned more than 1 million shares of iRobot Corporation at the end of June, down by 43% on the quarter.
Two companies that normally wouldn’t be mentioned in the same sentence, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Intel Corporation (NASDAQ:INTC) are making waves today after the two agreed to agreed to collaborate on creating a wearable health device to monitor patients’ conditions with Huntington’s disease. Although there are no FDA-approved drugs that can treat the fatal disease (Huntington’s causes nerve cells to progressively break down in the brain and leads to a decline in mental stability, motor control, and cognition), there are some approved medications that can treat some of the symptoms. Teva and Intel will deploy existing technology, such as smartphones, as well as tailor new technology such as smartwatches with special sensors and a cloud platform to processes the information, to better monitor the patients. Wearable health technology will be a growing market for both companies over the next two decades as baby boomers continue to age. Of the around 750 elite funds that we track, 55 were long Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and 57 funds had a bullish position in Intel Corporation (NASDAQ:INTC) at the end of June.
On the next page, we find out why Transocean and Seadrill are trending.